The new article “Quantitative Systems Pharmacology Model to Predict Target Occupancy by Bruton Tyrosine Kinase Inhibitors in Patients With B-Cell Malignancies” has been recently published. The work was supported by BeiGene.
The path of a Quantitative Systems Pharmacology company to optimize drug development
This year InSysBio celebrates its 20-year anniversary. Now InSysBio specializes in Quantitative Systems Pharmacology (QSP) modeling services and QSP software infrastructure development and operates in the global market.
The new article "Quantitative systems pharmacology model of α-synuclein pathology in Parkinson's disease-like mouse for investigation of passive immunotherapy mechanisms" by Olga Ivanova and Tatiana Karelina was published in PSPJournal at the end of August 2024
Now B cells model reflects the current views on the processes
InSysBio launches Immune Response Template (IRT) version 3.6.3. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system
InSysBio held its 14th Annual Internal Scientific Meeting on February 11-13, 2024. The Meeting was organized for the first time after the pandemic and InSysBio’s Headquarters relocation to Cyprus.
InSysBio’s Heta language is now supported by Sublime Text
InSysBio launches the new Plugin for Sublime Text editor to highlight Heta language code. Heta project is InSysBio’s initiative for the development of infrastructure for modeling in pharmacology and systems biology.
We use cookies (and other similar technologies) to collect data to improve your experience on our site.
By using our website, you agree to data collection as described in our website’s data collection policy.
First
Prev